Searchable abstracts of presentations at key conferences in endocrinology

ea0031p384 | Thyroid | SFEBES2013

Management of thyrotoxic crisis in a brittle asthmatic

Barrett George , Kankara Chenchi , Squires Phillipa , Malik Tass

A 35-year lady with Grave’s disease and brittle asthma presented to the Endocrinology team with symptoms and signs of thyrotoxic crisis. She was not on any anti-thyroid medication as she had previous suffered a severe rash in response to carbimazole, and profound gastrointestinal disturbance with propylthiouracil. It was suggested that she consider radioiodine to control her condition, but as a single parent with young children she was not prepared to undergo the isolatio...

ea0027p16 | (1) | BSPED2011

GH stimulation testing: how discrepant are its diagnostic tests?

Bhat Gayathri , Knight Olivia , Barrett Timothy , Kirk Jeremy

As the sensitivity of a single GH test is poor, current NICE guidelines (2010) state that to make a diagnosis of isolated GH deficiency (IGHD), two stimulation tests need to show subnormal peak GH levels. In our centre we use insulin tolerance (ITT) or glucagon stimulation (GST) as the 1st test, and arginine stimulation (AST) as the 2nd test.The purpose of this study was to identify the proportion of children with discrepant test results; and to establis...

ea0017p27 | (1) | BSPED2008

Long-term outcome of autosomal recessive pseudohypoaldosteronism

Bandhakavi M , Kirk J , Hogler W , Barrett T , Shaw N

Type 1 pseudohypoaldosteronism (PHA1), defined as resistance to aldosterone, is characterised by salt wasting, hyperkalemia and metabolic acidosis and is associated with high renin and aldosterone levels. The autosomal recessive form is characterised by generalised salt wasting and is due to a defect in the epithelial sodium channel. Whilst there are individual case reports on this condition, there are little published data on long-term outcome including neurodevelopment.<...

ea0017p52 | (1) | BSPED2008

Comparison of twice daily insulin and multiple daily insulin regimens in children and adolescents newly diagnosed with type 1 diabetes

Lyder G , Kirk J , Barrett T , Shaw N , Hogler W

Aims: To compare glycaemic control and change in body mass index (BMI) in children and adolescents newly diagnosed with type 1 diabetes (T1D) and started on either twice daily insulin (BD) or multiple daily insulin (MDI).Methods: This study looked retrospectively at all children newly diagnosed with T1D at our hospital from January 2006 to June 2007. There were 44 children and the outcome measures used were change in haemoglobin A1c (HbA1...

ea0011p641 | Neuroendocrinology and behaviour | ECE2006

Endocrine abnormalities are common in transsexual individuals

Iqbal SJ , Baig H , Green R , Barrett J , Seal LJ

Background: The most significant hypotheses regarding biological causes of transsexualism are based on the role of environmental hormonal exposure on neural development.Aim: This study was to analyse the baseline hormonal results in a population of transsexuals attending a single clinic to identify any abnormalities in hormone levels in these individuals.Method: A retrospective cohort study was carried out using data collected from...

ea0011p643 | Neuroendocrinology and behaviour | ECE2006

Complications of hormonal therapy in male to female transsexuals is uncommon

Baig H , Iqbal SJ , Green R , Barrett J , Seal LJ

Background: Transsexuals in Britain are prescribed hormones as part of Gender Reassignment Treatment. Oestrogen therapy is associated with the development of deep vein thrombosis (DVT) with a 25 fold increased risk, and breast cancer; particularly in the older age group and smokers.Aims: To investigate the risk of developing deep vein thromboses in male to female transsexual patients who are, or have been, on oestrogen therapy, and seeing if this differs...

ea0003p173 | Growth and Development | BES2002

Developmental regulation of the mt1 melatonin receptor gene in the rat pituitary gland

Johnston J , Messager S , Barrett P , Hazlerigg D

Expression of the mt1 melatonin receptor has been described in both the pars tuberalis (PT) and pars distalis (PD) of the rat pituitary gland. Expression of mt1 mRNA and iodomelatonin (IMEL) binding sites is high in the neonate PD but rapidly declines over the initial weeks of postnatal life. In contrast, both mt1 mRNA and IMEL binding sites are preserved in the PT through to adulthood, leading to a marked tissue-specific expression profile.To identify ...

ea0045p38 | Diabetes | BSPED2016

Introduction of an intensive outpatient education programme is acceptable to parents of children, and young people with newly diagnosed type 1 Diabetes

Kershaw Melanie , Krone Ruth , Drummond Lesley , Dias Renuka , Barrett Timothy

Objectives: Many successful European centres provide intensive education as 2 week inpatient admissions for newly diagnosed type 1 diabetes. Prolonged inpatient stay is resource intensive and disrupts the family unit. Our centre aimed to determine the feasibility of delivering an intensive education programme in an ambulatory care setting.Methods: The curriculum, introduced in October 2013, comprised 20 hours face to face education by paediatric diabetes...

ea0051oc5.7 | Oral Communications 5 | BSPED2017

The Phenotyping of Overgrowth (POD) Study: a novel ‘no win, no fee’ model for translating research findings into clinical diagnoses

Foster Alison , Antoniadi Thalia , Wallis Yvonne , Griffiths Mike , Lim Derek , Cole Trevor , Barrett Tim

Introduction: Rare genetic overgrowth disorders are a group of conditions characterised by height and/or head circumference >2 S.D. above the mean for age and sex, learning disability, congenital anomalies, and in some cases childhood tumours. POD is a national cohort study that includes a next generation sequencing (NGS) panel of overgrowth genes. We present a new model for clinical confirmation of pathogenic variants identified by this research panel. Clin...

ea0051oc7.3 | Oral Communications 7 | BSPED2017

Level of WFS1 protein expression correlates with clinical progression of optic atrophy in wolfram syndrome patients

Hu Kun , Astuti Dewi , Williams Denise , Dias Renuka , Barrett Timothy , Zatyka Malgorzata

Introduction: Wolfram Syndrome (DIDMOAD) is an autosomal recessive disease caused by mutations in WFS1 gene, resulting in childhood onset diabetes mellitus and optic atrophy. There have been limited functional assays for WFS1 genetic variants. We aimed to investigate WFS1 protein expression in patients and relate this to their genotype and phenotype.Methods: Nine patients from a regional paediatric centre consented to skin biopsies. Six patients had comp...